1) C57BL/6 MT(-/-)mice
C57BL/6MT(-/-)小鼠
1.
Methods Sixty-three C57BL/6 MT(-/-)mice were equally randomized into 9 groups.
方法取C57BL/6MT(-/-)小鼠63只,随机分为9组,每组7只,各组于每天上午9点至10点称重,正常对照组和模型组给予NS20mL·kg-1,蜂胶醇提物组分别给予12。
2) C57BL/6 mouse
C57BL/6小鼠
1.
Primary culture,purification,identification of myoblast neonatal C57BL/6 mouse in vitro;
新生C57BL/6小鼠成肌细胞体外培养、纯化和鉴定的实验研究
2.
Objective It is to find the better condition to establish melanoma animal model in C57BL/6 mouse.
目的利用C57BL/6小鼠制备黑色素瘤动物模型,选择合适的造模条件。
3) C57BL/6 mice
C57BL/6小鼠
1.
Relationship between inflammation in adventitia of femoral artery of C57BL/6 mice and the expression of adhesion molecule;
C57BL/6小鼠股动脉外膜炎症与内膜粘附分子的表达的关系
2.
Age-related hearing loss and inner ear morphological changes in C57BL/6 mice;
C57BL/6小鼠内耳形态学和年龄相关性听力损失的研究
3.
Anti-tumer effect of Trichinella spirialis on Hepa1-6 hepatoma carcinoma cell in the C57BL/6 mice
旋毛虫抗C57BL/6小鼠体内Hepa1-6肝癌细胞作用的研究
4) C57BL mouse
C57BL小鼠
1.
OBJECTIVE:To investigate the effect and mechanism of Huangbankang granule on pathologically changed C57BL mouse lens tissue structure with experimental dyslipidemia.
目的:探讨中药黄斑康颗粒剂对实验性血脂异常C57BL小鼠晶状体组织结构病理改变的影响。
2.
A variety of melanin-related animal models,such as zebrafish,Smyth line chicken,C57BL mouse,hairless mouse and brownish guinea pig are introduced in this paper and provide a valuable reference for future research.
通过介绍斑马鱼、Smyth line鸡、C57BL小鼠、无毛小鼠、棕黄色豚鼠等多种实验动物的研究用途,为黑色素的相关实验研究提供参考。
5) C57BL/10J mice
C57BL/10J小鼠
1.
Objective To investigate the morphological changes in the inner ear among C57BL/10J mice of varied age.
目的探讨不同月龄C57BL/10J小鼠内耳形态学变化。
6) C57BL mice
C57BL小鼠
1.
An affect of dyslipidemia on scleral compliance in experimental C57BL mice;
血脂异常对C57BL小鼠巩膜顺应性的影响
2.
Construction of MPTP-induced differentially expressed gene librarys of C57BL mice brain by suppression subtractive hybridization;
利用消减抑制杂交技术构建MPTP诱导的C57BL小鼠全脑差异表达基因文库
3.
Methods Lewis lung carcinoma cells were subcutaneously inoculated in C57BL mice to make animal model of tumor.
方法将Lewis肺癌细胞接种于C57BL小鼠皮下,成瘤后将30只小鼠随机分成3组,分别瘤体内注射血管能抑素重组载体、空载体和生理盐水,基因枪于注射部位电击,2周后PT-PCR法检测肿瘤组织中血管能抑素基因的表达并观察小鼠体重、肿瘤体积变化及肺转移结节数目。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条